From the ETF of the Year to the People’s Choice ETF, we review the winners of each award, what drove their success and the finalists they competed against.
Luck, circumstances or magic, these newcomers have had great debuts.
J.P. Morgan smashes its own record with its brand-new Canada ETF.
Financial giant’s plain-vanilla ETF lineup off to roaring start.
Global X plans new addition to its Strategic Beta lineup.
New ETF from Exchange Traded Concepts targets cancer immunotherapy treatments..
Commission-free ETF platform adds 18 funds.
The index provider says its indexes will include ‘foreign listed companies.’
iShares and Vanguard announce changes to their ETFs’ fees.